A detailed history of Regentatlantic Capital LLC transactions in Danaher Corp stock. As of the latest transaction made, Regentatlantic Capital LLC holds 33,439 shares of DHR stock, worth $7.66 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
33,439
Previous 32,766 2.05%
Holding current value
$7.66 Million
Previous $8.31 Million 3.97%
% of portfolio
0.26%
Previous 0.27%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $166,271 - $1.01 Million
673 Added 2.05%
33,439 $8.64 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $96,029 - $121,362
405 Added 1.25%
32,766 $8.31 Million
Q1 2022

May 02, 2022

BUY
$257.27 - $315.76 $238,489 - $292,709
927 Added 2.95%
32,361 $9.49 Million
Q4 2021

Jan 27, 2022

SELL
$292.08 - $329.01 $35,049 - $39,481
-120 Reduced 0.38%
31,434 $10.3 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $131,477 - $160,563
-483 Reduced 1.51%
31,554 $9.61 Million
Q2 2021

Aug 12, 2021

SELL
$225.08 - $271.69 $79,903 - $96,449
-355 Reduced 1.1%
32,037 $8.6 Million
Q1 2021

Apr 29, 2021

BUY
$212.38 - $245.9 $217,689 - $252,047
1,025 Added 3.27%
32,392 $7.29 Million
Q4 2020

Feb 04, 2021

BUY
$212.5 - $245.46 $243,525 - $281,297
1,146 Added 3.79%
31,367 $6.97 Million
Q3 2020

Oct 13, 2020

SELL
$177.16 - $215.33 $389,929 - $473,941
-2,201 Reduced 6.79%
30,221 $6.51 Million
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $200,385 - $275,324
1,557 Added 5.04%
32,422 $5.73 Million
Q1 2020

May 14, 2020

SELL
$121.39 - $169.05 $246,057 - $342,664
-2,027 Reduced 6.16%
30,865 $4.27 Million
Q4 2019

Feb 04, 2020

SELL
$133.47 - $153.48 $260,399 - $299,439
-1,951 Reduced 5.6%
32,892 $5.05 Million
Q3 2019

Oct 22, 2019

SELL
$135.4 - $146.47 $131,608 - $142,368
-972 Reduced 2.71%
34,843 $5.03 Million
Q2 2019

Jul 23, 2019

SELL
$124.88 - $143.73 $223,285 - $256,989
-1,788 Reduced 4.75%
35,815 $5.12 Million
Q1 2019

May 03, 2019

BUY
$97.62 - $132.29 $53,691 - $72,759
550 Added 1.48%
37,603 $4.96 Million
Q4 2018

Jan 30, 2019

BUY
$94.85 - $109.54 $190,458 - $219,956
2,008 Added 5.73%
37,053 $3.82 Million
Q3 2018

Oct 30, 2018

BUY
$98.13 - $108.9 $3,532 - $3,920
36 Added 0.1%
35,045 $3.81 Million
Q2 2018

Jul 31, 2018

SELL
$96.1 - $103.24 $130,311 - $139,993
-1,356 Reduced 3.73%
35,009 $3.46 Million
Q1 2018

Apr 23, 2018

SELL
$92.16 - $103.8 $137,226 - $154,558
-1,489 Reduced 3.93%
36,365 $3.56 Million
Q4 2017

Jan 23, 2018

SELL
$85.26 - $94.62 $153,297 - $170,126
-1,798 Reduced 4.53%
37,854 $3.51 Million
Q3 2017

Oct 25, 2017

BUY
$79.29 - $88.45 $3.14 Million - $3.51 Million
39,652
39,652 $3.4 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.